Insider · CIK 0001314981

DALTON JAMES T

Reports to the SEC for 1 company · MEMPHIS, TN

sec.gov

Transactions

Companies

Filings

CIK

0001314981

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-06-01	Oncternal Therapeutics, Inc.F Tax Payment	VP, Chief Scientific Officer	FTax Payment	−27.1K sh	$1.66	−$45K	72,883
2013-10-01	Oncternal Therapeutics, Inc.Nonstatutory Stock Option (Right to Buy)A Award	VP, Chief Scientific Officer	AAward	+100K sh	—	—	100,000
2013-10-01	Oncternal Therapeutics, Inc.A Award	VP, Chief Scientific Officer	AAward	+100K sh	—	—	100,000
2013-01-17	Oncternal Therapeutics, Inc.S Sale	VP, Chief Scientific Officer	SSale	−20K sh	$5.20	−$104K	0
2013-01-17	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	VP, Chief Scientific Officer	MExercise/Conversion	−20K sh	—	—	30,000
2013-01-17	Oncternal Therapeutics, Inc.M Exercise/Conversion	VP, Chief Scientific Officer	MExercise/Conversion	+20K sh	$2.65	+$53K	20,000
2013-01-01	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	VP, Chief Scientific Officer	AAward	+55K sh	$4.20	+$231K	55,000
2012-01-01	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	VP, Chief Scientific Officer	AAward	+35K sh	$3.36	+$118K	35,000
2011-01-01	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	VP, Chief Scientific Officer	AAward	+50K sh	$2.65	+$133K	50,000
2010-01-01	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	VP, Chief Scientific Officer	AAward	+35K sh	$4.20	+$147K	35,000
2009-01-01	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	VP, Chief Scientific Officer	AAward	+25K sh	$16.84	+$421K	25,000
2008-01-01	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	VP, Chief Scientific Officer	AAward	+25K sh	$14.35	+$359K	25,000
2007-01-01	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	VP, Chief Scientific Officer	AAward	+25K sh	$17.84	+$446K	25,000
2006-01-01	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	VP, Chief Scientific Officer	AAward	+20K sh	$7.56	+$151K	20,000
2005-05-19	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	VP, Chief Scientific Officer	AAward	+25K sh	$9.71	+$243K	25,000

Recent filings

Accepted (ET)
Jul 34
GTX INC /DE/0001179110-14-011493
SEC(opens sec.gov)
Oct 24
GTX INC /DE/0001179110-13-014969
SEC(opens sec.gov)
Jan 184
DALTON JAMES T0001209191-13-003652
SEC(opens sec.gov)
Jan 34
DALTON JAMES T0001209191-13-001544
SEC(opens sec.gov)
Jan 44
DALTON JAMES T0001209191-12-001462
SEC(opens sec.gov)
Jan 44
DALTON JAMES T0001209191-11-000993
SEC(opens sec.gov)
Jan 54
DALTON JAMES T0001209191-10-001173
SEC(opens sec.gov)
Jan 54
Dalton James T0001209191-09-001255
SEC(opens sec.gov)
Jan 24
GTX INC /DE/0001209191-08-000259
SEC(opens sec.gov)
Jan 34
GTX INC /DE/0001209191-07-000361
SEC(opens sec.gov)
Jan 44
Dalton James T0001209191-06-001408
SEC(opens sec.gov)
May 234
GTX INC /DE/0001209191-05-027537
SEC(opens sec.gov)

Companies

Oncternal Therapeutics, Inc.VP, Chief Scientific Officer

Address

175 TOYOTA PLAZA 7TH FLOOR

MEMPHIS, TN, 38103